Honliv Healthcare Management Group Company Limited

HKSE 9906.HK

Honliv Healthcare Management Group Company Limited Price to Earnings Ratio (P/E) on January 13, 2025: 29.70

Honliv Healthcare Management Group Company Limited Price to Earnings Ratio (P/E) is 29.70 on January 13, 2025, a -27.80% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Honliv Healthcare Management Group Company Limited 52-week high Price to Earnings Ratio (P/E) is 41.18 on January 26, 2024, which is 38.67% above the current Price to Earnings Ratio (P/E).
Honliv Healthcare Management Group Company Limited 52-week low Price to Earnings Ratio (P/E) is 27.28 on November 29, 2024, which is -8.13% below the current Price to Earnings Ratio (P/E).
Honliv Healthcare Management Group Company Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 33.83.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

HKSE: 9906.HK

Honliv Healthcare Management Group Company Limited

CEO	Mr. Yan Qin
IPO Date	July 13, 2020
Location	China
Headquarters	No. 8, Bo Ai Road (South)
Employees	1,953
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

Honliv Healthcare Management Group Company Limited owns and operates a general hospital in Mainland China. The company provides medical and pharmaceutical services, and hospital management services. It also operates as the pharmaceutical wholesaler. As of December 31, 2021, the company operated and managed Henan Honliv Hospital with 1,500 beds in operation located in Henan Province. The company was founded in 2004 and is headquartered in Changyuan, China. Honliv Healthcare Management Group Company Limited is a subsidiary of Sunny Rock Capital Limited.

Key trends

Past 5 years